Nucleotide Reverse Transcriptase Inhibitors: A Thorough Review, Present Status and Future Perspective as HIV Therapeutics

Publisher： Bentham Science Publishers

E-ISSN： 1873-4251|15|6|411-421

ISSN： 1570-162X

Source： Current HIV Research, Vol.15, Iss.6, 2018-01, pp. : 411-421

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Coumarins as Inhibitors of HIV Reverse Transcriptase

By  

Current HIV Research, Vol. 4, Iss. 3, 2006-01 ,pp. : 347-363

Bentham Science Publishers

Access to resources Recommend Favorite

Reverse Transcriptase Inhibitors as Microbicides

By  

Current HIV Research, Vol. 10, Iss. 1, 2012-01 ,pp. : 27-35

Bentham Science Publishers

Access to resources Recommend Favorite

Past, Present, and Future of Entry Inhibitors as HIV Microbicides

By  

Current HIV Research, Vol. 10, Iss. 1, 2012-01 ,pp. : 19-26

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetics of 400 mg of raltegravir once daily in combination with atazanavir/ritonavir plus two nucleoside/nucleotide reverse transcriptase inhibitors

By Calcagno A.   Tettoni M. C.   Simiele M.   Trentini L.   Montrucchio C.   D'Avolio A.   Di Perri G.   Bonora S.  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 2, 2013-02 ,pp. : 482-484

Oxford University Press

Access to resources Recommend Favorite

The Use of Nucleoside Reverse Transcriptase Inhibitors Sparing Regimens in Treatment-Experienced HIV-1 Infected Patients

By  

Current HIV Research, Vol. 11, Iss. 3, 2013-04 ,pp. : 179-186

Bentham Science Publishers

Access to resources Recommend Favorite